MedTrace Logo

Ultrasound Grayscale Analysis in ARDS covid19

NCT04863534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2021-04-28

No results posted yet for this study

Summary

Recent evidence regarding the novel coronavirus disease 2019 (COVID19) is growing in describing the characteristics of this disease, with main focus on lung morphology. Few data are available regarding the peripheral and respiratory muscular characteristics. Using a ultrasound greyscale analysis, It Is possibile to evaluated the muscle quality.

The hypothesis of this studi is that a combined assessment of respiratory (i.e., intercostal and diaphragm) and peripheral (i.e., quadriceps) muscles quantity (as measured by thickness) and quality (as assessed by greyscale analysis), would reflect the severity of illness. Thus,the aims of this study are to assess if the quality characteristics of parasternal intercostal, diaphragm and quadriceps muscles of ICU COVID19 patients influenced the outcomes and are correlated with other variables, such as fluid or protein balance, or indexes of inflammation

Conditions

  • Muscular Diseases
  • COVID-19 Acute Respiratory Distress Syndrome

Interventions

DEVICE

Ultrasound

Muscular grayscale ultrasound

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2021-02-21
Completion
2021-02-21

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863534 on ClinicalTrials.gov